Navigation Links
Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
Date:12/15/2009

revenues which were generated in the quarter.

Costs of Personalized Oncology Services for the second quarter totaled ($13,000) as compared to $369,000 in fiscal 2009. This reduction is due to the decrease in Personalized Oncology panel services year over year. In addition, during the quarter the Company recognized a one-time $125,000 credit and change in estimate for accrued costs of a personalized oncology study agreement.

Research and development ("R&D") expenses for the second quarter of fiscal 2010 were $645,000 as compared to $417,000 in the comparable quarter of fiscal 2009, an increase of 55%. This increase is primarily due to licensing fees and costs of $208,000 in connection with licensing our second oncology drug, TAR-1.

General and administrative expenses for the second fiscal quarter of 2010 were $891,000 as compared to $354,000 in the comparable quarter of 2008. This increase is primarily due to our development of corporate infrastructure to support our effort to grow our Preclinical eValuation Services and includes increased payroll, legal, accounting, marketing, and office rent expenses.

For the second quarter ended October 31, 2009 the Company reported a net loss of $584,000 or ($0.02) per share compared to a net loss of $161,000 or $0.00 per share for the corresponding quarter in fiscal 2009.

The Company's cash position on October 31, 2009 was $394,000 compared to $1,728,000 at April 30, 2009.

For the six-month period ended October 31, 2009, revenues were $2,251,000 compared to $1,717,000 for the comparable period last year, an increase of 31%. Total operating expenses which include research and development and general and administrative, were $2,838,000 compared to $1,337,000 for the comparable period last year, an increase of 112% and the Company reported a net loss of $1,587,000 or ($0.05) per share, as compared to a net loss of $292,000 or ($0.01) per share for the comparabl
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
2. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
3. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
4. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
5. TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
6. Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
7. Biotechnology Salutes Americas Veterans; Innovations Continue to Offer Improved Treatment and Care of Combat Troops
8. NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations
9. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
10. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... AMBOY, N.J. , Sept. 29, 2014 ... accept customer service inquiries via Twitter, the social media ... to Tweet inquiries and issues related to customer service ... Twitter,s ubiquitous use and its accessibility from any ... Medical Center to better serve its patients and community. ...
(Date:9/29/2014)... , Sept. 29, 2014 Tianyin ... ), a pharmaceutical company that specializes in patented ... and active pharmaceutical ingredients (API), today announced that ... official site visit by the China Food & ... (GMP) certification. In early September 2014, ...
(Date:9/29/2014)... Sept. 29, 2014  Diplomat, the nation,s largest ... has been named chief information officer. As ... the information technology department while being responsible for ... and external partnerships. Prior to joining ... in the development of technology architectures and organizational ...
Breaking Medicine Technology:@myrbmc: Healthcare Customer Service Support in 140 Characters or Less 2TPI's QLF Completes GMP site inspection by CFDA 2TPI's QLF Completes GMP site inspection by CFDA 3Diplomat names Stephen S. Brown chief information officer 2
... Dec. 6, 2011  Therakos, Inc., a pioneer in ... immune modulation therapy, today announced that the first ... clinical study evaluating the use of the company,s ... moderate-to-severe chronic Graft-versus-Host Disease (GvHD). An estimated 15,000 ...
... Dec. 6, 2011 Mobile patient monitoring innovator ... to collaborate with Qualcomm Life Inc., a wholly ... execute a home health monitoring initiative that integrates ... Qualcomm 2net™Platform. The initial focus of AirStrip,s initiative ...
Cached Medicine Technology:First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 2First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 3AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life 2AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life 3
(Date:9/30/2014)... New York, NY (PRWEB) September 30, 2014 ... an award-winning managed IT solutions firm based in ... contract to deploy CRA’s Manage360° solution to transform, ... NYC-based Nonprofit Organization (NPO) who is a leading ... become healthy, productive, and self sufficient. The ...
(Date:9/30/2014)... 2014 All on Four dental ... persons who have received dental implants to vigilant in ... post. , The post, which can be found at ... if they don’t brush and floss diligently, they could ... their natural teeth: the bone will deteriorate and the ...
(Date:9/30/2014)... September 30, 2014 Signet Puerto ... based in San Juan, Puerto Rico, leverages RamSoft’s ... , Nivia Souffront, site Administrator for Signet ... “We are excited to bring in PowerServer RIS/PACS/PM ... patient care and physician satisfaction while reducing our ...
(Date:9/30/2014)... Westminster, Maryland (PRWEB) September 30, 2014 3M ... of acrylic very high bond tapes. 3M 5906 , ... 3M 5909 are conformable VHBs which help create the ... acrylic foam tapes are used for bonding to difficult surfaces ... , 3M VHBs 5906, 5907, 5908, and 5905 are designed ...
(Date:9/30/2014)... Doctors often order breast ultrasounds as a follow-up, after a ... are done at a specialized medical imaging center, such as ... The Center for Diagnostic Imaging is now offering breast ultrasounds ... find ultrasounds to be more comfortable as they can be ... perfectly still. , “We realize that receiving abnormal ...
Breaking Medicine News(10 mins):Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Breast Ultrasounds Are a Comfortable and Convenient Option for Patients and Referring Doctors 2
... bacteria, scientists had been able to use light as ... cavity. ,The dental samples obtained from patients suffering ... to 520nm). The light had selectively killed oral black-pigmented ... samples obtained from patients. Medium strength light had killed ...
... team from the University of Western Ontario had found out that ... ,The study used a robot arm to show how ... the video of this learning process was shown to a group, ... the people in the video. Moreover people who learned the same ...
... scientists, consuming food with high glycemic index have been //linked ... which had spanned 16.6 years and observed the incidence of ... is much significant for women who are past their menopause. ... foods that have simple carbohydrates and sugars like refined flour, ...
... can lead to mothers being less emotionally involved with ... a new study done by researchers of Pennsylvania State ... pregnancy and childbirth was previously related to post-partum depression ... The new study suggests that bonding with their newborns ...
... the second phase of testing of the vaccine for ... cancers and 90% of genital warts. ,277 women ... months and regularly had gynecological examination, cervicovaginal sampling for ... to HPV. , ,The results showed the incidence ...
... the pattern of rising early from bed in the mornings ... ,The behavior is called familial advanced sleep phase ... is said to be the phenotype of the gene PER2. ... the phosphorylation site in the casein kinase I (CKI) domain ...
Cached Medicine News:
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
... a threaded titanium anchor, specifically ... The anchor features wide threads ... optimize bone purchase, as well ... prevent suture binding. Fastin RC ...
The GII titanium anchor is the "Gold Standard" for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor of choice ...
... Proxis features 'proximal protection' -- providing ... removal, even in vessels with side branches. ... to use. It does not require the ... removal of embolic debris. ,Proxis is ...
Medicine Products: